MARKET

NARI

NARI

Inari Medical, Inc.
NASDAQ
38.70
-0.40
-1.02%
Pre Market: 39.50 +0.8 +2.07% 08:39 04/18 EDT
OPEN
39.22
PREV CLOSE
39.10
HIGH
39.78
LOW
38.48
VOLUME
3
TURNOVER
0
52 WEEK HIGH
71.85
52 WEEK LOW
38.35
MARKET CAP
2.24B
P/E (TTM)
-1343.7500
1D
5D
1M
3M
1Y
5Y
BUZZ-Truist bets on a 'beat & raise' Q1 for some med-tech players
Brokerage Truist Securities expects Q1 results beat and forecast raises for medical device makers Boston Scientific Corp BSX.N and Intuitive Surgical. Truist believes medical-technology sector will see rising earnings this quarter. Medical device makers have been benefitting from a resurgence in demand for joint replacements.
Reuters · 3d ago
Weekly Report: what happened at NARI last week (0408-0412)?
Weekly Report · 3d ago
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
Needham sees BSX, CNMD, RMD and Surmodics beating Street, despite medtech slow down. Needham estimates medtech sales grew less than expected in Q1, but that Boston Scientific, CONMED and ResMed should still beat the Street. The investment firm says medtech market only grew by 5.3% in the first quarter of 2024.
Seeking Alpha · 3d ago
What 8 Analyst Ratings Have To Say About Inari Medical
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. The company has an average 12-month price target of $66.75. 8 analysts have expressed a variety of opinions on Inari Medical over the past quarter. The average price target has decreased by 8.06% from the previous $72.60.
Benzinga · 6d ago
Inari Medical Is Maintained at Buy by Canaccord Genuity
Dow Jones · 6d ago
Inari Medical Price Target Maintained With a $75.00/Share by Canaccord Genuity
Dow Jones · 6d ago
The Implied Analyst 12-Month Target For SPSM
NASDAQ · 6d ago
Inari Medical Announces the Release of 2023 Ethos and Sustainability Report
Inari Medical, Inc. Releases its 2023 Ethos and Sustainability Report. The report highlights Inari's commitment to its ethos and environmental, social and governance initiatives. Inari is a medical device company with a mission to treat and transform the lives of patients.
Barchart · 04/11 15:05
More
About NARI
Inari Medical, Inc. is a medical device company. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss.

Webull offers Inari Medical Inc stock information, including NASDAQ: NARI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NARI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NARI stock methods without spending real money on the virtual paper trading platform.